Royal Fishing Pharmaceutical takes scientific and technological innovation as the strategic core, scientific quality as the strategic basis, and product research and development as the strategic goal, and gradually builds the R & D structure of Royal Fishing with one "center "(R & D center) as the center and link, four" research institutes "as the base, in line with three" combination "way. Through the rational layout of "research and development generation, planning generation", we carry out in-depth cooperation with well-known universities, scientific research institutions, CRO enterprises, etc., focusing on the innovative research and development of the three product systems of traditional Chinese medicine, chemical medicine, and biological medicine in terms of laboratory construction, drug research and development platform construction, product development and research and team building, and gradually form the transformation from outsourcing research and development to independent research and development. With the focus on generic drug research and development to high-end preparations, innovative drug research and development, and domestic research and innovation to accelerate international development, Royal Fishing will be built into China's top R & D capabilities, international innovative enterprises.
R&d strategy and information research, chemical and pharmaceutical business management, Chinese medicine business management, Clinical medicine, international drug registration, Government affairs, general operations, human resources; Positioning: planning, system, platform, project, progress monitoring and development promotion
Beijing Institute of Materia Medica, Harbin Institute of Materia Medica, Shanghai Institute of Materia Medica, Hangzhou Institute of Biological Medicine
Three combinations:The combination of imitation and creation, the combination of cooperative introduction and self-research, the combination of domestic registration and import and export registration
Stable layout:Research and development generation, planning generation
The company adheres to the research and development concept of "three pillars" of traditional Chinese medicine, chemical medicine and biological medicine. In order to cooperate with Royal Fishing to comprehensively promote the "1234" strategic project, based on the advantages of Royal Fishing Company's traditional Chinese medicine foundation, it rapidly expands into the field of chemical medicine and biological medicine. Lead Royal Fishing Pharmaceutical to achieve high-tech, high quality and high efficiency development.
Continue to enrich the product pipeline, and develop new Chinese medicine products such as formula particles and hospital preparations
Idea advantage: Research and development concept of international standards
Talent advantage: Advanced research and development team led by domestic and foreign core experts
Equipment advantage: National leading cutting-edge experimental equipment
Resource advantage: Establish close cooperation with international and domestic frontier institutions
Independent research and development Secondary development co-development Invest in research and development Cooperative introduction
Pharmaceutical innovation drug research and development platform Generic drug research and development platformChemical and high-end preparations research and development platform Traditional Chinese medicine innovative drug research and development platformChinese medicine hospital preparation research and development platform Chinese medicine formula granule research and development platform Drug clinical research platform
Royal Fishing Pharmaceutical actively promotes the construction of core scientific research team, and has set up a professional research and development team with research and development concepts integrating with Europe and the United States. At present, it has nearly 200 R & D personnel, including more than 60 talents with doctor's and master's degrees and high professional titles, and the main technical backbone has more than 10 years of experience in new drug research. In the future, we will continue to actively cultivate and introduce highly skilled R&D technical talents in pharmaceutical specialties to lay a solid talent foundation for innovative drug R&D.
